European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Blood products tenders in France

Blood products tenders in France: 204 listed on GranTender since 2024; 2 open now. The median awarded contract value is about €4,100,000 (124 contracts with a stated value). Buyers with the most tenders: Hopital Nord Ouest - Villefranche sur Saone (34), Centre Hospitalier de l'Agglomération de Nevers (11) and APHP Sorbonne Université (10); suppliers with the most contract awards: Octapharma France (65), LFB Biomedicaments (64) and Takeda France (59). Sources: DECP, BOAMP and TED. In 2025 the median contract value was €6.9 million; 6% of contracts drew a single bid (8.5 bids on average). Data as of 18 November 2026; updated daily.

Tenders
204
Open tenders
2
Awards
424
Awarded value awarded
€3,298,495,051
Awarded value contract
€12,864,773,821
Awarded value framework ceiling
€3,632,131,095
Median contract value contract
≈ €5,200,000
Median contract value framework ceiling
≈ €4,600,000
Median contract value awarded
≈ €4,100,000
Average bids per contract
10.6
Tenders in 2025
157 +481% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

Latest tenders

TenderBuyerEstimated valueStatusPublished
FOURNITURE DE MÉDICAMENTS DÉRIVÉS DU SANG 2027Centre Hospitalier Universitaire de Nice - Hôpital de CIMIEZ - Établissement support du GHT06€132,655,777Open22 October 2026
Fourniture de greffons issus de membranes amniotiques en vue d’allogreffes cornéennes et de greffons de cornées humaines pour le compte du CHNO des Quinze-Vingts - Greffons issus de membranes amniotiques en vue d’allogreffes cornéennes (cryoconservés)CHNO des 15-20—Awarded27 July 2026
Fourniture de greffons issus de membranes amniotiques en vue d’allogreffes cornéennes et de greffons de cornées humaines pour le compte du CHNO des Quinze-Vingts - Greffons de cornées humainesCHNO des 15-20—Awarded27 July 2026
Fourniture d’immunoglobulines humaines pour les Etablissements de santé du MorbihanCentre hospitalier Bretagne Atlantique€59,453,000Closed12 July 2026
Fourniture de matériels de prélèvement biologique et autres produits associés : tubes et dispositifs médicaux de prélèvement pour sang et urine lot 7 Tubes, accessoires pour micro prélèvements inférieur à 1,5ML lot 9 Microtube de prélèvement avec citrate dCHR Metz-Thionville—Awarded17 June 2026
Fourniture de greffons issus de membranes amniotiques et greffons de cornées humainesCHNO des 15-20—Closed9 May 2026
Fourniture d’héparine bas poids moléculaire pour les établissements et structures associées du GHT44 (2 lots)Centre Hospitalier Universitaire de Nantes—Awarded22 April 2026
Fourniture d’héparine bas poids moléculaire pour les établissements et structures associées du GHT44 (2 lots) - La présente consultation comporte deux lots.Centre Hospitalier Universitaire de Nantes—Awarded15 April 2026
Convention fourniture de produits sanguins labilesCentre Hospitalier Universitaire Caen Normandie—Awarded1 April 2026
Fourniture de Médicaments de la classe ATC « V » DIVERS, solutés versables et d’irrigation : Immunoglobulines antidigitaliques ovines, Pralidoxime, Vert d'indocyanine35 CHU—Awarded16 March 2026
Fourniture de produits sanguins labilesCentre Hospitalier Intercommunal de Mont de Marsan—Awarded3 February 2026
Fourniture de spécialités pharmaceutiques - Immunoglobulines Humaines Polyvalentes - Lot 4Centre Hospitalier de l'Agglomération de Nevers—Awarded29 December 2025
Fourniture de spécialités pharmaceutiques- Immunoglobulines Humaines Polyvalentes Lot 3Centre Hospitalier de l'Agglomération de Nevers—Awarded29 December 2025
Fourniture d’héparine bas poids moléculaire pour les établissements et structures associées du GHT44 (2 lots)Centre Hospitalier Universitaire de Nantes—Closed17 December 2025
Fourniture de médicaments dérivés du sangAPHP Sorbonne Université€950,000,000Closed12 December 2025
MACROGREGATS ALBUMINE HUMAINECHU de Toulouse—Awarded21 November 2025
UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie GéniqueHospices Civils de Lyon—Open19 November 2025
Les prestations attendues au titre du présent marché sont : la fourniture, le transport et la livraison des équipements et intrants de laboratoire, dans les pays bénéficiaires du projet. - Intrants de laboratoires (réactifs et consommables)Institut de Recherche pour le Developpement—Awarded1 October 2025
Achat de greffons osseux viro-inactivés Ostéopure™ pour la Banque de tissus de l’EFS PACA CorseEtablissement Français du Sang—Awarded22 September 2025
Immunoglobulines Humaines Polyvalentes par voie Intraveineuse - IMMUNOGLOBULINES HUMAINES POLYVALENTES 5% - SOLUTION INJECTABLECentre Hospitalier de l'Agglomération de Nevers—Awarded29 August 2025

Competition and prices

In 2025, half of the contracts were worth between €1.8 million and €37 million, with a median of €6.9 million (141 contracts with a stated contract value). Contracts drew 8.5 bids on average (median 12) and 6% drew a single bid — based on 124 contracts with a known number of bids. The usual procedures: open procedure (76%), restricted procedure (15%), negotiation without a call for competition (9%) — of 34 tenders with a stated procedure.

The most contracts went to Octapharma France (65), LFB Biomedicaments (64) and Takeda France (59) — together 44% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2025313€6.9 million (contract value)€1.8 million – €37 million8.56% (124)
All years424€5.2 million (contract value)€920,000 – €26 million10.67% (213)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 7% of the 139 contracts with a known number of bids had a single bid; the median was 7 bids. The number of bids is known for 139 of the 329 contracts from procedures with competition.

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33141500 Haematological consumables
  • 33651500 Immune sera and immunoglobulins

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Blood products and immunoglobulins in neighbouring countries

Today, 5 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. In countries outside the EU and the EEA, the notice says who may bid. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon1

ExpectedBuyerWhatWhy we expect itConfidence
Jan – Feb 2027
every year
Centre Hospitalier Intercommunal de Mont de MarsanBlood products and immunoglobulins
Fourniture de produits sanguins labiles
The buyer has published blood products tenders every year in February since 2025.
Earlier tenders: 02/2026, 02/2025
medium

Forecast from public data, not an announcement. Methodology.

Market reports

Blood products and immunoglobulins by city

Blood products and immunoglobulins in other countries

Blood products and immunoglobulins across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which blood products tenders in France are open now?
2 of the 204 blood products tenders in France listed on GranTender are open for bids. For example: FOURNITURE DE MÉDICAMENTS DÉRIVÉS DU SANG 2027; UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique.
Where can I find blood products tenders in France?
GranTender lists them in one place, from DECP, BOAMP and TED, with their buyers, winners and contract values; 2 are open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most blood products tenders in France?
By number of contracts won: Octapharma France (65), LFB Biomedicaments (64), Takeda France (59).
Which buyers publish the most blood products tenders in France?
By number of tenders: Hopital Nord Ouest - Villefranche sur Saone (34), Centre Hospitalier de l'Agglomération de Nevers (11), APHP Sorbonne Université (10).
Which CPV codes belong to “Blood products and immunoglobulins”?
33141500 Haematological consumables; 33651500 Immune sera and immunoglobulins; plus tenders without a usable CPV code whose title names the topic.
How many bids do blood products tenders in France receive on average?
In 2025, contracts drew 8.5 bids on average (median 12) and 6% drew a single bid — based on 124 contracts with a known number of bids.
How much are contracts for blood products tenders in France worth?
In 2025, half of the contracts were worth between €1.8 million and €37 million, with a median of €6.9 million (141 contracts with a stated contract value).
Which procedures are used for blood products tenders in France?
The usual procedures: open procedure (76%), restricted procedure (15%), negotiation without a call for competition (9%) — of 34 tenders with a stated procedure.

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.